Advertisement
Product › Details
Thyrogen®
Next higher product group | thyrotropin alpha (INN) | |
Status | 1998-12-01 registration start | |
Organisation | Genzyme General (division, tracking stock) | |
Today | Genzyme Corporation (Sanofi Genzyme) | |
Group | Sanofi (Group) [since May 2011] | |
Record changed: 2023-07-10 |
Advertisement
More documents for hormone
- [1] Ascendis Pharma A/S. (5/11/20). "Press Release: Ascendis Pharma A/S Will Appoint Jesper Høiland as Global Chief Commercial Officer". Copenhagen....
- [2] Ascendis Pharma A/S. (8/28/19). "Press Release: Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results". Copenhagen....
- [3] Ascendis Pharma A/S. (3/4/18). "Press Release: Ascendis Pharma Announces Once-weekly TransCon Growth Hormone Demonstrated Superiority on Primary Endpoint Compared to a Daily Growth Hormone in Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency"....
- [4] Ascendis Pharma A/S. (4/2/18). "Press Release: Ascendis Pharma A/S Appoints Thomas A. Larson as Chief Commercial Officer". Copenhagen....
- [5] Ascendis Pharma A/S. (3/28/18). "Press Release: Ascendis Pharma A/S Reports Full Year 2017 Financial Results". Copenhagen....
- [6] Ascendis Pharma A/S. (3/19/18). "Press Release: Ascendis Pharma Announces Two Posters on Rare Disease Pipeline Programs at ENDO 2018". Copenhagen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top